What Is the Utility of Tumor Growth Rate in Glioma Treatment?ByTimothy F. Cloughesy, MDJune 4th 2026Timothy F. Cloughesy, MD, spoke with CancerNetwork after presenting data from the INDIGO trial, evaluating vorasidenib in IDH1/2-mutant glioma.